These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6728124)

  • 1. Dopaminergic and noradrenergic responses in the hippocampal slice preparation. Evidence for different receptors.
    Marciani MG; Calabresi P; Stanzione P; Bernardi G
    Neuropharmacology; 1984 Mar; 23(3):303-7. PubMed ID: 6728124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenergic responses in rat hippocampus: evidence for medication by alpha and beta receptors in the in vitro slice.
    Mueller AL; Hoffer BJ; Dunwiddie TV
    Brain Res; 1981 Jun; 214(1):113-26. PubMed ID: 6263414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenergic responses in rat hippocampus: electrophysiological actions of direct- and indirect-acting sympathomimetics in the in vitro slice.
    Mueller AL; Kirk KL; Hoffer BJ; Dunwiddie TV
    J Pharmacol Exp Ther; 1982 Dec; 223(3):599-605. PubMed ID: 6128402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors determining the efficacy of distal excitatory synapses in rat hippocampal CA1 pyramidal neurones.
    Andreasen M; Lambert JD
    J Physiol; 1998 Mar; 507 ( Pt 2)(Pt 2):441-62. PubMed ID: 9518704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal noradrenergic responses in vivo and in vitro. Characterization of alpha and beta components.
    Mueller AL; Palmer MR; Hoffer BJ; Dunwiddie TV
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Mar; 318(4):259-66. PubMed ID: 6281666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenergic potentiation of excitatory transmitter action in cerebrocortical slices: evidence for mediation by an alpha 1 receptor-linked second messenger pathway.
    Mouradian RD; Sessler FM; Waterhouse BD
    Brain Res; 1991 Apr; 546(1):83-95. PubMed ID: 1677306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic modulation of cholinergic responses in rat medial prefrontal cortex: an electrophysiological study.
    Yang CR; Mogenson GJ
    Brain Res; 1990 Aug; 524(2):271-81. PubMed ID: 1981327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of excitability and inhibitory processes in hippocampal dentate gyrus by noradrenaline: a pharmacological study in awake, freely moving rats.
    Sara SJ; Bergis O
    Neurosci Lett; 1991 May; 126(1):1-5. PubMed ID: 1678149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of norepinephrine in the dentate gyrus: beta-mediated facilitation of evoked potentials in vitro.
    Lacaille JC; Harley CW
    Brain Res; 1985 Dec; 358(1-2):210-20. PubMed ID: 3000513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norepinephrine induces pathway-specific long-lasting potentiation and depression in the hippocampal dentate gyrus.
    Dahl D; Sarvey JM
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4776-80. PubMed ID: 2734319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency-dependent noradrenergic modulation of long-term potentiation in the hippocampus.
    Hopkins WF; Johnston D
    Science; 1984 Oct; 226(4672):350-2. PubMed ID: 6091272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T; Todo N; Sasa M
    Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium reduced synaptic transmission and increased neuronal excitability without altering endogenous serotonin, norepinephrine and dopamine in rat hippocampal slices in vitro.
    Lacaille JC; Cloutier S; Reader TA
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 May; 16(3):397-412. PubMed ID: 1350356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of iontophoretically applied norepinephrine and dopamine on fimbria-evoked activity in the lateral septum.
    Marchand JE; Hagino N
    Exp Neurol; 1983 Dec; 82(3):683-97. PubMed ID: 6653717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization.
    Godbout R; Mantz J; Pirot S; Glowinski J; Thierry AM
    J Pharmacol Exp Ther; 1991 Aug; 258(2):728-38. PubMed ID: 1865369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of dopamine receptors mediating inhibition of excitatory synaptic transmission in the rat hippocampal slice.
    Hsu KS
    J Neurophysiol; 1996 Sep; 76(3):1887-95. PubMed ID: 8890301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of norepinephrine in seizurelike activity of hippocampal pyramidal cells maintained in vitro: alteration by 6-hydroxydopamine lesions of norepinephrine-containing systems.
    Mody I; Leung P; Miller JJ
    Can J Physiol Pharmacol; 1983 Aug; 61(8):841-6. PubMed ID: 6414679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered neuronal responsiveness to biogenic amines in rat cerebral cortex after serotonin denervation or depletion.
    Ferron A; Descarries L; Reader TA
    Brain Res; 1982 Jan; 231(1):93-108. PubMed ID: 6275953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice.
    Colmers WF; Lukowiak K; Pittman QJ
    J Physiol; 1987 Feb; 383():285-99. PubMed ID: 2821236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenergic depression of synaptic responses in hippocampus of rat: evidence for mediation by alpha 1-receptors.
    Mynlieff M; Dunwiddie TV
    Neuropharmacology; 1988 Apr; 27(4):391-8. PubMed ID: 2843779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.